![](/img/cover-not-exists.png)
Phase III, randomized, double-blind, placebo-controlled, multicenter study of lipegfilgrastim in patients with non-small cell lung cancer receiving myelosuppressive therapy
Volovat, Constantin, Bondarenko, Igor M, Gladkov, Oleg A, Elsässer, Reiner, Buchner, Anton, Bias, Peter, Müller, UdoVolume:
4
Language:
english
Journal:
SpringerPlus
DOI:
10.1186/s40064-015-1067-7
Date:
December, 2015
File:
PDF, 1013 KB
english, 2015